US--China health exchange and collaboration following COVID-19.

Citation metadata

Date: June 12, 2021
From: The Lancet(Vol. 397, Issue 10291)
Publisher: Elsevier B.V.
Document Type: Report; Brief article
Length: 220 words

Document controls

Main content

Abstract :

Summary Strong US--China collaboration on health and medicine is a crucial element of the global effort against COVID-19. We review the history of health collaboration and exchanges between the public and private sectors in the USA and China, including the long-lasting collaboration between governmental public health agencies of the two countries. Academic and scientific exchanges should be reinvigorated and the increasing valuable role of non-profit foundations acknowledged. The shared interests of the two countries and the magnitude of the pandemic necessitate both countries to collaborate and cooperate. We provide recommendations to the two governments and the global health community to control the ongoing COVID-19 pandemic and prepare for future threats. Translation For the Chinese translation of the abstract see Supplementary Materials section. Author Affiliation: (a) Center for Public Health and Epidemic Preparedness and Response, Peking University, Beijing, China (b) ThinkTank Research Center for Health Development, Beijing, China (c) College of Public Health, The University of Georgia, Athens, GA, USA (d) Centre for Health Economics, School of Economics, University of Nottingham, Ningbo, China (e) Emory Global Health Institute, Emory University, Atlanta, GA, USA * Correspondence to: Dr Jeffrey P Koplan, Emory Global Health Institute, Emory University, Atlanta, GA 30322, USA Byline: Prof Liming Li, MD (a), Kean Wang, MD (b), Zhuo Chen, PhD (c,d), Prof Jeffrey P Koplan, MD [jkoplan@emory.edu] (e)

Source Citation

Source Citation   

Gale Document Number: GALE|A664848912